March 5, 2024Open Access

In vitro activity of cefepime/taniborbactam and comparator agents against Gram-negative bacterial bloodstream pathogens recovered from patients with cancer

Key Points

Key points are not available for this paper at this time.

Abstract

Taniborbactam is a β-lactamase inhibitor that, when combined with cefepime, may offer a potential treatment option for patients with serious and resistant Gram-negative bacterial (GNB) pathogens.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Gerges et al. (Tue,) studied this question.

www.synapsesocial.com/papers/68e75a00b6db6435876d0e42 — DOI: https://doi.org/10.1093/jacamr/dlae060

Authors

Bahgat Gerges

Joel Rosenblatt

Y-Lan Truong

Journals

JAC-Antimicrobial Resistance

Actions

Institutions

The University of Texas MD Anderson Cancer Center

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

In vitro activity of cefepime/taniborbactam and comparator agents against Gram-negative bacterial bloodstream pathogens recovered from patients with cancer

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Cite this study

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion